Kadimastem Ltd. engages in developing cell therapy in the field of regenerative medicine. It develops a platform for the development and production of embryonic stem cells and various engineered pluripotent stem cells for the purpose of developing cell drugs as off-the-shelf products in the field of regenerative medicine. The company was founded by Yossi Ben Yosef and Michel Revel on October 6, 2008 and is headquartered in Ness Ziona, Israel.